Record ID | ia:taurine2basiccli0000unse |
Source | Internet Archive |
Download MARC XML | https://archive.org/download/taurine2basiccli0000unse/taurine2basiccli0000unse_marc.xml |
Download MARC binary | https://www.archive.org/download/taurine2basiccli0000unse/taurine2basiccli0000unse_meta.mrc |
LEADER: 01459cam a2200325 a 4500
001 96032064
003 DLC
005 20080310122319.0
008 960726s1996 nyua b 101 0 eng c
010 $a 96032064
020 $a0306453851
040 $aDNLM/DLC$cDLC$dDLC
050 00 $aQP801.T3$bT37 1996
060 10 $aW1 AD559 v.403 1996$aQU 60 T2287 1996
082 00 $a612/.0157$220
245 00 $aTaurine 2 :$bbasic and clinical aspects /$cedited by Ryan J. Huxtable ... [et al.].
246 30 $aTaurine two
260 $aNew York :$bPlenum Press,$cc1996.
300 $axiii, 658 p. :$bill. ;$c26 cm.
440 0 $aAdvances in experimental medicine and biology ;$vv. 403
440 4 $aThe language of science
500 $a"Proceedings of the International Taurine Symposium '95, an official satellite symposium of the 15th Biennial Meeting of the International Society for Neurochemistry, held June 27-July 1, 1995, in Osaka, Japan"--T.p. verso.
504 $aIncludes bibliographical references and index.
650 0 $aTaurine$xPhysiological effect$xCongresses.
650 0 $aTaurine$xTherapeutic use$xCongresses.
650 12 $aTaurine$xcongresses.
700 1 $aHuxtable, Ryan J.
710 2 $aInternational Society for Neurochemistry.$bMeeting$n(15th :$d1995 :$cOsaka, Japan)
711 2 $aInternationalTaurine Symposium '95$d(1995 :$cOsaka, Japan)
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/enhancements/fy0820/96032064-t.html